angiotensin ii has been researched along with zidovudine in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Iyer, SN; Katovich, MJ; Lu, D; Raizada, MK | 1 |
Chen, T; Chin, MT; Dai, DF; Dorn, GW; Johnson, SC; Kang, YJ; Marcinek, DJ; Nieves-CintrĂ³n, M; Prolla, TA; Rabinovitch, PS; Santana, LF; Villarin, JJ | 1 |
2 other study(ies) available for angiotensin ii and zidovudine
Article | Year |
---|---|
Chronic control of high blood pressure in the spontaneously hypertensive rat by delivery of angiotensin type 1 receptor antisense.
Topics: Angiotensin II; Animals; Autoradiography; Dose-Response Relationship, Drug; Gene Transfer Techniques; Humans; Hypertension; Oligonucleotides, Antisense; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Zidovudine | 1996 |
Mitochondrial oxidative stress mediates angiotensin II-induced cardiac hypertrophy and Galphaq overexpression-induced heart failure.
Topics: Angiotensin II; Animals; Cardiomegaly; Catalase; DNA Damage; DNA, Mitochondrial; Gene Expression Regulation; GTP-Binding Protein alpha Subunits, Gq-G11; Heart Failure; Mice; Mice, Transgenic; Mitochondria, Heart; Models, Animal; Myocytes, Cardiac; Oxidative Stress; Reactive Oxygen Species; Reverse Transcriptase Inhibitors; Zidovudine | 2011 |